申请人:Intellikine, LLC
公开号:EP3153023A1
公开(公告)日:2017-04-12
The present invention provides chemical entities or compounds and pharmaceutical compositions thereof that are capable of modulating certain protein kinases such as mTor, tyrosine kinases, and/or lipid kinases such as PI3 kinase. Also provided in the present invention are methods of using these compositions to modulate activities of one or more of these kinases, especially for therapeutic applications.
本发明提供了能够调节某些蛋白激酶(如 mTor)、酪氨酸激酶和/或脂质激酶(如 PI3 激酶)的化学实体或化合物及其药物组合物。本发明还提供了使用这些组合物调节一种或多种这些激酶活性的方法,特别是用于治疗的方法。